Aarti Pharmalabs (AARTIPHARM.BO) Earnings Analysis
Aarti Pharmalabs (AARTIPHARM.BO) has no confirmed upcoming earnings date. Trailing P/E 32.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AARTIPHARM.BO next report earnings?
No confirmed upcoming earnings date is currently scheduled for AARTIPHARM.BO. This page updates as the calendar is published.
AARTIPHARM.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 6.74 INR | n/a | n/a | n/a |
| 2026-02-04 | 8.16 INR | n/a | n/a | n/a |
AARTIPHARM.BO valuation and analyst view
| Trailing P/E | 32.28 |
|---|---|
| Trailing EPS | 20.565 INR |
| Price / book | 2.83 |
| Dividend yield | 0.60% |
| Market cap | 60.98B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Aarti Pharmalabs (AARTIPHARM.BO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AARTIPHARM.BO. This page updates as the calendar is published.
Did AARTIPHARM.BO beat earnings last quarter?
Consensus estimate data was not available for AARTIPHARM.BO's 2026-05-08 report.
What is AARTIPHARM.BO's current P/E ratio and EPS?
AARTIPHARM.BO trades at a trailing P/E of 32.28 on trailing EPS of 20.565324567451583 INR.
What do analysts rate AARTIPHARM.BO?
AARTIPHARM.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.